Ferumoxytol comment watch save
BreastfeedingGeriatricPediatric

  • TRADE NAME: Feraheme (AMG Pharma)
  • INDICATIONS: Iron deficiency anemia in adults with chronic kidney disease
  • CLASS: Iron supplement
  • HALF-LIFE: 15 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

May cause hypersensitivity reactions, hypotension and iron overload. Feraheme may transiently affect magnetic resonance (MRI) imaging for up to 3 months following dosage.

Contra-indicated in patients with evidence of iron overload or anemia not caused by iron deficiency.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top